TherapeuticsMD (TXMD) Operating Income (2011 - 2026)
TherapeuticsMD (TXMD) posted Operating Income of -$723000.0 for Q1 2026, up 53.41% on a QoQ basis from -$1.6 million in Q4 2025, and up 43.56% year-over-year from -$503623.2 in Q1 2025.
TherapeuticsMD (TXMD) Operating Income (2011 - 2026) Analysis & Trends
TherapeuticsMD's Operating Income history runs 16 years deep, the most recent figure standing at -$723000.0 for Q1 2026.
- Quarterly Operating Income rose 43.56% year-over-year to -$723000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.8 million (up 34.56% YoY) and the FY2025 annual result came in at -$4.4 million, up 28.17% from the prior year.
- Operating Income was -$723000.0 for Q1 2026 at TherapeuticsMD, up from -$1.6 million in the prior quarter.
- Across five years, Operating Income topped out at $48.4 million in Q4 2022 and bottomed at -$17.9 million in Q1 2022.
- A 5-year average of -$1.1 million and a median of -$1.6 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income soared 236.87% — and 2025, when it sank 138.04%.
- TherapeuticsMD's Operating Income stood at $48.4 million in 2022, then slumped by 103.33% to -$1.6 million in 2023, then soared by 59.53% to -$652000.0 in 2024, then sank by 138.04% to -$1.6 million in 2025, then surged by 53.41% to -$723000.0 in 2026.
- Business Quant data shows TXMD's Operating Income at -$723000.0 in Q1 2026, -$1.6 million in Q4 2025, and -$862000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | -723,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -723,000.00 |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | -862,000.00 |
| Jun 30, 2025 | -695,000.00 |
| Mar 31, 2025 | -1.28 Mn |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -2.79 Mn |
| Mar 31, 2024 | -1.14 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -1.77 Mn |
| Jun 30, 2023 | -2.47 Mn |
| Mar 31, 2023 | -2.67 Mn |
| Dec 31, 2022 | 48.44 Mn |
| Sep 30, 2022 | -14.52 Mn |
| Jun 30, 2022 | -14.86 Mn |
| Mar 31, 2022 | -17.88 Mn |
| Dec 31, 2021 | -35.39 Mn |
| Sep 30, 2021 | -39.92 Mn |
| Jun 30, 2021 | -35.18 Mn |